ES2665312T3 - Cristal de 4-(3 -benciloxifeniltio) - 2-cloro-1-(3 -nitropropil)benceno - Google Patents

Cristal de 4-(3 -benciloxifeniltio) - 2-cloro-1-(3 -nitropropil)benceno Download PDF

Info

Publication number
ES2665312T3
ES2665312T3 ES13778567.1T ES13778567T ES2665312T3 ES 2665312 T3 ES2665312 T3 ES 2665312T3 ES 13778567 T ES13778567 T ES 13778567T ES 2665312 T3 ES2665312 T3 ES 2665312T3
Authority
ES
Spain
Prior art keywords
benzyloxyphenylthio
nitropropyl
chloro
ethanol
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13778567.1T
Other languages
English (en)
Inventor
Takeshi Tsubuki
Hiroya Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2665312T3 publication Critical patent/ES2665312T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un cristal de 4-(3 -benciloxifeniltio) - 2-cloro-1-(3 -nitropropil)benceno, en donde, en una difracción de rayos X de polvo que utiliza radiación Cukα, donde 2θ representa un ángulo de difracción, se observa una imagen de difracción de rayos X de polvo que contiene los siguientes picos: 2θ: 9.7, 12.9, 16.4, 16.8, 17.6, 19.5, 21.7, 22.6, 22.9, 23.3, 24.5, 24.8, 26.0, 26.4, 27.2.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
para disolver el compuesto 1 y a continuación se enfrió a -20ºC, y se añadió metanol (0,20 ml). Después de confirmar que la cristalización tuvo lugar (-20ºC), la mezcla se calentó a 28ºC para disolver parte de los cristales (parte de los cristales permanecieron sin disolver). Se añadió metanol (0,70 ml) a la mezcla resultante a 27ºC, y a continuación se añadió agua (0,50 ml) a 27ºC. Después de que se enfriara la mezcla a 0ºC, los cristales recogidos
5 mediante filtración y secados para obtener el compuesto 1 (90,4 mg) en un rendimiento del 86,9%.
El mismo procedimiento se realizó para el Ciclo 1 y el Ciclo 3 al 16. Sin embargo, únicamente en el Ciclo 16, se añadieron los cristales simientes (peso no medido) junto con la adición de metanol.
Los resultados se muestran en la TABLA 1. En la TABLA 1, IPE hace referencia a éter diisopropílico, e IPA hace referencia a 2-propanol.
10 [TABLA 1]
Ciclo
CANTIDAD DE COMPUESTO 1 UTILIZADO DISOLVENTE A (CANTIDAD UTILIZADA) DISOLVENTE B (CANTIDAD UTILIZADA) DISOLVENTE C (CANTIDAD UTILIZADA) DISOLVENTE D (CANTIDAD UTILIZADA) TEMPERATURA DE CRISTALIZACIÓN a) (TEMPERATURADE FILTRACIÓN) RECUPERACIÓN PUNTO DE FUSIÓN (MÉTODO DE LA PLACA CALIENTE)
1
103 mg IPE (0,50 ml) METANOL (0,20 ml) METANOL (0,30 ml) ___ -20ºC (-18ºC) 66,5% 46º~47ºC
2
104 mg IPE (0,50 ml) METANOL (0,30 ml) METANOL (0,70 ml) AGUA (0,50 ml) -20ºC (0ºC) 89,9% 46º~47ºC
3
113 mg IPE (0,50 ml) ETANOL (0,20 ml) ___ ___ -15ºC (-15ºC) 61,9% 46º~47ºC
4
106 mg IPE (0,50 ml) ETANOL (0,20 ml) ___ ___ -10ºC (-10ºC) 71,7% 46º~47ºC
5
102 mg IPE (0,50 ml) ETANOL (0,20 ml) ___ ___ -21ºC (-21ºC) 68,6% 46º~47ºC
6
100 mg IPE (0,50 ml) ETANOL (0,50 ml) ___ ___ -20ºC (-20ºC) 76,0% 46º~47ºC
7
116 mg IPE (0,23 ml) ETANOL (0,23 ml) ETANOL (0,46 ml) ___ -20ºC (-20ºC) 77,6% 46º~47ºC
8
107 mg IPE (0,50 ml) ETANOL (0,15 ml) ETANOL (0,25 ml) AGUA (0,10 ml) -20ºC (-20ºC) 80,4% 46º~47ºC
9
102 mg IPE (0,40 ml) ETANOL (0,30 ml) ETANOL (0,50 ml) AGUA (0,40 ml) -19ºC (-19ºC) 81,4% 46º~47ºC
10
112 mg Acetato de etilo (0,20 ml) METANOL (0,10 ml) METANOL (0,90 ml) ___ -21ºC (-21ºC) 83,9% 46º~48ºC
11
102 mg Acetato de etilo (0,20 ml) METANOL (0,40 ml) METANOL (0,60 ml) AGUA (0,50 ml) -16ºC (0ºC) 88,4% 47ºC
12
112 mg Acetato de etilo (0,20 ml) ETANOL (0,20 ml) ETANOL (0,80 ml) ___ -20ºC (-20ºC) 83,9% 46º~47ºC
13
107 mg Acetato de etilo 1-Propanol (0,60 ml) 1-Propanol (0,40 ml) ___ -21ºC (-21ºC) 75,7% 46º~47ºC
7
imagen6
imagen7
imagen8
imagen9

Claims (1)

  1. imagen1
ES13778567.1T 2012-04-18 2013-04-17 Cristal de 4-(3 -benciloxifeniltio) - 2-cloro-1-(3 -nitropropil)benceno Active ES2665312T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012094758 2012-04-18
JP2012094758 2012-04-18
PCT/JP2013/002585 WO2013157255A1 (ja) 2012-04-18 2013-04-17 4-(3-ベンジルオキシフェニルチオ)-2-クロロ-1-(3-ニトロプロピル)ベンゼンの結晶

Publications (1)

Publication Number Publication Date
ES2665312T3 true ES2665312T3 (es) 2018-04-25

Family

ID=49383225

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13778567.1T Active ES2665312T3 (es) 2012-04-18 2013-04-17 Cristal de 4-(3 -benciloxifeniltio) - 2-cloro-1-(3 -nitropropil)benceno

Country Status (13)

Country Link
US (1) US9315453B2 (es)
EP (1) EP2840079B1 (es)
JP (1) JP6062424B2 (es)
KR (1) KR102025962B1 (es)
CN (1) CN104379562B (es)
AU (1) AU2013250625A1 (es)
CA (1) CA2868252A1 (es)
ES (1) ES2665312T3 (es)
IN (1) IN2014DN07856A (es)
MX (1) MX2014012435A (es)
RU (1) RU2014146161A (es)
TW (1) TWI554493B (es)
WO (1) WO2013157255A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461212C (en) * 2001-09-27 2010-08-17 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
EP1806338B1 (en) * 2004-10-12 2016-01-20 Kyorin Pharmaceutical Co., Ltd. Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof
CA2718987C (en) * 2008-03-24 2016-03-08 Kyorin Pharmaceutical Co., Ltd. Method for crystallization of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol hydrochloride

Also Published As

Publication number Publication date
US9315453B2 (en) 2016-04-19
CN104379562A (zh) 2015-02-25
KR102025962B1 (ko) 2019-09-26
CA2868252A1 (en) 2013-10-24
IN2014DN07856A (en) 2015-04-24
CN104379562B (zh) 2016-06-01
AU2013250625A1 (en) 2014-10-09
TWI554493B (zh) 2016-10-21
RU2014146161A (ru) 2016-06-10
US20150073178A1 (en) 2015-03-12
EP2840079A4 (en) 2015-11-18
JPWO2013157255A1 (ja) 2015-12-21
EP2840079A1 (en) 2015-02-25
EP2840079B1 (en) 2018-02-21
MX2014012435A (es) 2014-12-10
KR20150002665A (ko) 2015-01-07
WO2013157255A1 (ja) 2013-10-24
TW201348188A (zh) 2013-12-01
JP6062424B2 (ja) 2017-01-18

Similar Documents

Publication Publication Date Title
AR071246A1 (es) Proceso para la preparacion de compuestos utiles como inhibidores de sglt
AR098260A2 (es) Polimorfo cristalino de una sal de bisulfato de un antagonista del receptor de trombina, proceso para su preparación, composición y forma purificada
RU2009132660A (ru) Полиморфные формы макроциклического ингибитора hcv
ES2649412T3 (es) Polimorfos de benfotiamina, procedimiento de preparación y uso de los mismos
Shang et al. An I2O5-promoted decarboxylative trifluoromethylation of cinnamic acids
PE20221579A1 (es) Derivados de indol mono o disustituidos como inhibidores de la replicacion viral del dengue
RU2007144531A (ru) Новые кристаллические формы тиотропийбромида
RU2014126351A (ru) Новая кристаллическая форма тикагрелора и способ ее получения
ME02655B (me) Spojevi dimetilbenzojeve kiseline, korisni u liječenju upalnih stanja
HRP20171245T1 (hr) Postupak za proizvodnju velikih razmjera monohidrata 1-[(2-bromofenil)sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil)metil]-1h-indol dimezilata
CY1116086T1 (el) Ενυδρη υδροχλωρικη αγομελατινη και παρασκευη αυτης
HRP20210667T1 (hr) Kristalni oblici antagonista androgenog receptora, postupak pripreme i njihova upotreba
PE20140592A1 (es) Proceso para la preparacion de derivados de benzoimidazol-2-il pirimidina
ES2543804T3 (es) Polimorfo B de Ibandronato
ES2620660T3 (es) Método para la fabricación de naltrexona
Kolvari et al. Aryl diazonium nanomagnetic sulfate and potassium iodide: an iodination process
ES2665312T3 (es) Cristal de 4-(3 -benciloxifeniltio) - 2-cloro-1-(3 -nitropropil)benceno
NZ608557A (en) New crystalline forms of the sodium salt of (4-{ 4-[5-(6-trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl} - cyclohexyl)-acetic acid
RU2014104991A (ru) Полиморфные формы натриевой соли 4-трет-бутил-n-[4-хлор-2-(1-окси-пиридин-4-карбонил)-фенил]-бензолсульфонамида
RU2016134404A (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА α МОНОБЕНЗОАТА СОЕДИНЕНИЯ А, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ЕЕ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
CN103626718A (zh) 盐酸普拉克索的工业化制备方法
Liu et al. Efficient synthesis of unsymmetrical S-(bromodifluoromethyl) diarylsulfonium salts for electrophilic bromodifluoromethylating reagents
CN104829575A (zh) 一种6-氟吡喃衍生物的制备方法
CN104844549A (zh) 一种7-溴吡喃衍生物的制备方法
CN104860910A (zh) 一种8-氟吡喃衍生物的制备方法